1. James WD, Berger TG, Elston DM, Odom RB. Andrews' diseases of the skin: clinical dermatology. 2006. 10th ed. Philadelphia: Saunders Elsevier;69–77.
2. Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976. 6:468–475.
Article
3. Mueller W, Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979. 301:555.
Article
4. Nousari CH, Anhalt GJ. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Immunosuppressive and immunomodulatory drugs. Fitzpatrick's dermatology in general medicine. 2008. 7th ed. New York: McGraw-Hill;2217–2223.
5. Lee CS, Koo JYM. Wolverton SE, editor. Cyclosporine. Comprehensive dermatologic drug therapy. 2007. 2nd ed. Indiana: Saunders Elsevier;219–238.
6. Hijnen DJ, ten Berge O, Timmer-de Mik L, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol. 2007. 21:85–89.
Article
7. Harper JI, Berth-Jones J, Camp RD, Dillon MJ, Finlay AY, Holden CA, et al. Cyclosporin for atopic dermatitis in children. Dermatology. 2001. 203:3–6.
Article
8. Campbell DE, Kemp AS. Cyclosporine restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol. 1997. 99:857–859.
Article
9. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000. 142:52–58.
Article
10. Park C, Kang YS, Lee CH. Immunologic changes after treatment with cyclosporine A in atopic dermatitis. Korean J Dermatol. 1993. 31:210–216.
11. Lee SW, Lee YS, Lee SC. The effect of cyclosporin in the treatment of childhood atopic dermatitis. Korean J Dermatol. 2000. 38:466–471.
12. Lee JH, Kim KH, Park KC, Chung JH, Suh DH. The efficacy of cyclosporine in patients with severe atopic dermatitis. Ann Dermatol. 2001. 13:12–15.
Article
13. Garcia-Bustinduy M, Escoda M, Guimera FJ, Saez M, Dorta S, Fagundo E, et al. Safety of long-term treatment with cyclosporin A in resistant chronic plaque psoriasis: a retrospective case series. J Eur Acad Dermatol Venereol. 2004. 18:169–172.
Article
14. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980. 92:44–47.
15. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy. 2001. 56:841–849.
Article
16. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997. 195:10–19.
Article
17. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007. 157:645–648.
Article
18. Lee JS, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC. The efficacy of cyclosporin in patients with atopic dermatitis. Korean J Dermatol. 2008. 46:224–230.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003. 289:2560–2572.
Article
20. Leung DYM, Eichenfield LF, Boguniewicz M. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Atopic dermatitis. Fitzpatrick's dermatology in general medicine. 2008. 7th ed. New York: McGraw-Hill;146–158.
21. Bunikowski R, Staab D, Kussebi F, Brautigam M, Weidinger G, Renz H, et al. Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol. 2001. 12:216–223.
Article
22. Lee SS, Tan AW, Giam YC. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study. Ann Acad Med Singapore. 2004. 33:311–313.
23. Granlund H, Erkko P, Remitz A, Langeland T, Helsing P, Nuutinen M, et al. Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis. Acta Derm Venereol. 2001. 81:22–27.
Article
24. Okudaira H, Sakurai Y, Terada K, Terada E, Ogita T, Miyamoto T. Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse. Int Arch Allergy Appl Immunol. 1986. 79:164–168.
Article
25. Eynott PR, Salmon M, Huang TJ, Oates T, Nicklin PL, Chung KF. Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology. 2003. 109:461–467.
Article